Intrexon | XON - Current Liabilities

Stock Price
4.13
Daily Change
0.17 4.29%
Monthly
33.23%
Yearly
175.33%
Q2 Forecast
4.04

Intrexon reported $23.02M in Current Liabilities for its fiscal quarter ending in June of 2024.





Current Liabilities Change Date
Agenus USD 323.49M 36.36M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Amgen USD 25.49B 3.7B Dec/2025
Anika Therapeutics USD 21.91M 2.82M Dec/2025
Arrowhead Research USD 347.42M 151.94M Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Heron Therapeutics USD 96.1M 6.39M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
Intrexon USD 23.02M 38K Jun/2024
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025
Ligand Pharmaceuticals USD 37.45M 6.91M Dec/2025
MacroGenics USD 43.11M 1.36M Dec/2025
MannKind USD 171.03M 61.9M Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 27.28B 4.72B Dec/2025
Rigel Pharmaceuticals USD 94.4M 7.76M Sep/2025
Roche Holding CHF 28B 421M Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Thermo Fisher Scientific USD 14.62B 568M Mar/2026
Veracyte USD 59.94M 12.22M Dec/2025
Xencor USD 95.91M 9.42M Dec/2025